†rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

ACCOUNTSOVERVIEW OF SUBSIDIARIESParent companyNominalShare capitalShareof equityNYCOMED HOLDING A/S, Roskilde, Denmark DKK 10.0 million -SubsidiariesNycomed Danmark A/S, Roskilde, Denmark DKK 800.0 million 100 %SubsidiariesNettopharma, Roskilde, Denmark DKK 9.3 million 100 %Nycomed Consumer A/S, Roskilde, Denmark DKK 4.0 million 100 %Nycomed Pharma GmbH, Germany EUR 0.5 million 100 %Nycomed Christiaens B.V., Holland NLG 29.656 million 100 %SubsidiariesChristiaens B.V., Holland NLG 0.040 million 100 %APIC B.V., Holland NLG 0.035 million 100 %Sandipro B.V., Holland NLG 0.100 million 100 %Christiaens GmbH., Germany DEM 0.050 million 100 %Christiaens Pharma N.V., Belgium BEF 1.250 million 100 %Silochemie B.V., Holland NLG 0.040 million 100 %Sandipro N.V., Belgium BEF 1.250 million 100 %Centrapharm N.V., Belgium BEF 11.000 million 100 %Exel Pharma N.V., Belgium BEF 1.250 million 100 %DEP B.V.B.A., Belgium BEF 0.75 million 100 %Nycomed Christiaens N.V., Belgium BEF 225 million 100 %SubsidiariesNycomed Austria GmbH, Austria ATS 131.0 million 100 %SubsidiariesNycomed AG, Switzerland CHF 0.5 million 100 %Nycomed Hellas SA, Greece GRD 50.0 million 100 %Nycomed East EuropeMarketing Service G.m.b.H., Austria ATS 0.5 million 100 %Nycomed Hungaria KFT, Hungaria HUF 1.0 million 100 %Chemisch Pharmazeutische ForschungsGmbH., Austria ATS 0.5 million 100 %Nycomed Spol S.R.O., Czeck CZK 0.1 million 100 %* Linz Roberts Inc./USA. USD 0.005 million 50 %Nycomed A/O Moskau, Russia RUR 50.0 million 100 %Dynapharm GmbH., Austria ATS 0.5 million 100 %Nycomed Distribution Center T.O.O.,Moscow USD 0.04 million 100 %Nycomed Bratislava, Slovakia CZK 0.1 million 100 %* Nycomed Siberia RUR 24.0 million 80 %* The companies have been excluded from consolidation, ref. Danish CompanyAccounts Act § 2b, as they are of immaterial importance for a true and fair viewof the consolidated accounts.–62–